Of note, the prevalence of CLL cells expressing the adverse prognostic markers ZAP70 and CD38 was significantly higher in the NFAT2-deficient cohort (Fig. 3h). This evidence concerns the gene NFATC1 and B-cell chronic lymphocytic leukemia.